Appearance information

- aqueous phase: [domestic, export 1, export 3]
colorless vial with white to contain a pale yellow powder

[export 2]
white ~ g of pale yellow powder. in a colorless transparent vial, colorless, transparent solvent are all injections in a clear colorless ampoules

[export 4]
is a white to pale yellow powder, all the vials

Ingredient information

Ceftriaxone sodium hydrate 1 g

How to Save

Sealed container, stored at room temperature (1-30 ° C)

Efficacy effect

1. Effective species
(Group B), Streptococcus agalactiae (group B), Streptococcus viridans, Streptococcus viridans, Streptococcus pneumoniae , Streptococcus pyrogens (Group A-beta hemolytic), Streptococcus agalactiae Wu streptococci, erotic Pseudomonas, Alcaligenes, morak Cellar Kata LAL-less, in a sheet bakteo, Enterobacter bakteo (some strains resistant), Escherichia coli, chancroid bacteria, influenza strains (including the ampicillin resistant strains), parainfluenza bacteria, Cleve when (Including pemphigus vulgaris), meningococcus, morganella morgani, proteus mirabilis, proteus vulgaris, providensia, gonorrhea (including penicillinase-producing bacteria), meningococcal bacteria, phlegmonaceous sielloididase,

2. Indications
- Respiratory tract infection such as pneumonia, bronchitis
- Otorhinolaryngology
- Renal and urinary tract infection , gonorrhea including gonorrhea
- Sepsis
Prevention of infection before and after surgery
- Bone and joint infection
- Skin, wound and soft tissue infection
- Gastrointestinal tract infection such as peritonitis , cholecystitis , cholangitis
- Infections in patients with impaired immune function
- meningitis

Usage Capacity

(Injection)
○ Adults and children 12 years and older: As ceftriaxone, inject 1 ~ 2g (titer) once a day intravenously or intramuscularly.
Infections caused by pathogens showing severe disease or moderate susceptibility can be increased up to 4g (potency) once a day.
○ Newborns: For newborns (within 14 days of birth), 20-50 mg / kg of body weight (titer) is administered once a day and does not exceed 50 mg / kg of body weight.
There is no need to separate premature infants and normal infants.
Young, infants and children (15 to 12 years of age): 20 to 80 mg / kg of body weight per day (titer) should be administered once a day. In children less than 50 Kg should be administered to the adult sangyongryang, when the weight per Kg 50 mg (potency) than intravenous drip injection is at least 30 minutes vein.
○ Elderly person: It does not need to change adult dosage and dosage.
Meningitis ○: the case of bacterial meningitis in infants and children with the initial capacity is [not exceed the total daily 4g (potency)] is administered once a day Kg body weight per 100 mg (potency).
As soon as pathogens and their susceptibility are known, capacity can be reduced accordingly. The following treatment period was found to be effective.
Meningococcus: 4 days
Influenza: 6 days
Streptococcus pneumoniae: 7 days
Gonorrhea: A 250 mg (titer) single intramuscular injection is recommended for the treatment of gonorrhea with penicillin susceptible and resistant bacteria.
○ Prevention of infection before and after surgery: It is recommended to administer 1 ~ 2g (titer) before surgery 30 ~ 90 minutes depending on the risk of infection in order to prevent infection after surgery. It is effective to administer this drug and 5-nitro-imidazole (eg oruridazole) separately at the time of colon rectal surgery separately.
○ Renal and hepatic dysfunction: In patients with renal dysfunction, if the liver function is normal, there is no need to decrease the dose. However, in the end-stage renal failure with a creatinine clearance of less than 10 mL / min , it does not exceed 2 g (titer) per day.
Patients with hepatic impairment need not decrease the dose if the renal function is normal. If you have severe renal and hepatic insufficiency, you should routinely measure your blood plasma concentration. In dialysis patients, additional administration after dialysis is not necessary, but since the excretion rate of dialysis patients may be reduced, the blood concentration should be measured to determine the need for dosage adjustment.


The duration of the treatment depends on the condition of the disease and should be administered for at least 48 to 72 hours after the fever has disappeared or the pathogen has been confirmed, as is usually the case with other antibiotics.